NASA Partners with Katalyst to Save Swift Observatory with Innovative Docking Mission 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies 
Ancient Mars may have had a carbon cycle − a new study suggests the red planet may have once been warmer, wetter and more favorable for life 
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now 
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options 
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback 
Tabletop particle accelerator could transform medicine and materials science 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
Having a stroke inflicts several problems on the human body that, if left untreated, could significantly impair normal functions. One of the worst effects of a stroke includes damage to brain cells, which can lead to permanent mobility issues. Thanks to a newly developed drug, the damage caused by a stroke to the brain could be mitigated and can even help repair damaged cells.
The new drug in question is interleukin-1 receptor antagonist (IL-1Ra) and was developed by The University of Manchester researchers, which addresses the damage caused by stroke due to the reduction of blood flowing to the brain, MedicalXpress reports. Due to stroke cutting off blood flow to the brain, oxygen deprivation would set in, which is what kills brains cells that then lead to disabilities and even death.
By promoting neurogenesis, which is basically a means of healing damaged brains cells, the new drug that the researchers created is able to help treat the damage that previous stroke incidents induced. The double benefits have staggering implications for stroke victims, largely because it means that even those who already experienced the health episode can still take advantage of the new drug.
Right now, the results are only based on tests done on mice, but future experiments involving humans is already being planned. Previous research into the development of new treatments for stroke victims failed to produce substantial results, Science Daily reports, and this is the first one to actually have a tangible potential for producing a viable treatment.
On a side note, the drug used in the test has actually been applied to the direct effects of stroke before, with encouraging results. By applying IL-1Ra to rodents that experienced a stroke and were thus left impaired, the drug helped the mice regain bodily function. If this can be applied to humans, even stroke victims left fully paralyzed could have a hope of walking again.
